Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...

Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...

The key opportunities in the Global Personalized Medicine Biomarkers Market include advancements in genomic sequencing, growing reliance on targeted therapies, rising cancer and chronic disease ...

Ultima Genomics, Hamilton partner to enable improved lab operations to drive sequencing at scale: Fremont, California Saturday, February 28, 2026, 11:00 Hrs [IST] Ultima Genomics, ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global Next Generation Sequencing (NGS) market is witnessing rapid expansion, driven by technological innovation and the growing importance of genomics in ...

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...

Builds on success of existing partnership including development of automated library preparation methods on SPT Labtech’s ...

Peter Fromen, CEO of biomodal, said: "We designed our technology to be platform agnostic to ensure researchers have access to the highest quality multiomic data. Through this partnership with Element, ...

By Dusty Vyas, Senior Scientist at LGC Biosearch Technologies Targeted GBS  The application of targeted genotyping by sequencing (targeted GBS) in | Genetics And Genomics ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...